
Presenter(s): Katie Fitzgerald Jones PhD, ACHPN, CARN-AP
Target Audience: This activity is designed for physicians, advanced practice professionals, nurses, psychologists, pharmacists, social workers, residents/fellows, health professional students, and other mental health clinicians. This activity is accredited for physicians, nurses, PAs, pharmacists, interprofessional teams, and other health professionals.
Credit Designations Available: AMA PRA Category 1 Credit™, AAPA Category 1 CME, Nursing Contact Hours, Pharmacy CE Credit, Interprofessional Continuing Education (IPCE) Credit
Webinar Description:This activity focuses on buprenorphine for the treatment of chronic pain by reviewing different formulations and the evidence-base supporting its use for chronic pain with and without Opioid Use Disorder. Participants learn how to apply the evidence of buprenorphine’s effectiveness to different patient scenarios.
Educational Objectives:
- Compare different buprenorphine formulations and their indications
- Examine the evidence on buprenorphine for chronic pain with and without Opioid Use Disorder
- Apply the evidence to patient scenarios including decision-making of buprenorphine dosage and titration
- Review perioperative management of buprenorphine and its use with full opioid agonists